Jump to:

Philip Morris

Suspension of Dow Purchases

Date: 07 May 1984
Length: 2 pages
2023799799-2023799800
Jump To Images
snapshot_pm 2023799799-2023799800

Fields

Author
Latshaw, R.D.
Type
MEMO, MEMORANDUM
Document File
2023799679/2023799822/Operations 940000 - 860000
Area
PM USA/CARLSTADT
Request
Stmn/R1-004
Stmn/R1-071
Copied
Morgan, L.W.
Adkins, G.C.
Harris, W.B.
Named Organization
Dow Chemical
Merrell
Smoking Cessation Newsletter
Site
N308
Named Person
Morgan, L.W.
Bujold, J.
Butler, A.
Harris, W.B.
Ihrig, R.
Latshaw, R.D.
Master ID
2023799789/9807

Related Documents:
Litigation
Stmn/Produced
Stmn/Trial Exhibit P-11696
Txag/Trial Exhibit P-12624
Txag/Trial Exhibit P-15684
Stmn/Selected
Author (Organization)
PM, Philip Morris
Recipient
Kay, A.J., J.R.
Recipient (Organization)
PM, Philip Morris
Date Loaded
27 Feb 1998
UCSF Legacy ID
vqy74e00

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: vqy74e00
PHILIP MORRIS U. S. A. INTER-OFFICE CORRESPQNDENCE RICHNOMD. YIRBiMIA To: . Mr. A. J. Kay, Jr. From: . R. D. Latshaw subj.ct: . SUSPENSION OF DOW PURCHASES Dat.: May 7, 1984 Per our conversations, we ceased issuing glycerine, propylene glycol, and triethylene glycol orders to Dow. They requested a meeting to discuss the situation which was held on Wednesday, May 2. Dow attendees were Ron Ihrig, District Manager; Joe Bujold, Corporate Accounts Manager; and Tony Butler, Sales Representative. Representing Philip Morris were L. W. Morgan, W. B. Harris, and R. D. Latshaw. Dow was told that we were discontinuing all humectant purchases because of Dow-Merrell's attack on cigarette smoking associated with the intro- duction of Nicorette, a nicotine-containing prescription chewing gum which reportedly aids "patients" in quitting smoking. Specific examples of Dow's objectionable campaign were cited: 1.. Efforts to encourage all smokers at their Freeport Plant (source of most of our materials) to give up cigarettes. 2. The Dow sponsored Policy Analysis Incorporated study indicating an additional $59,000 lifetime medical expense for smokers. 3. Dow literature appearing in doctors' offices encouraging smokers to quit- by using Nicorette. 4. A new Richmond doctors' clinic discouraging smoking and offering Nicorette. Through a series of meetings over the past few years, Dow had been repeat- edly advised of our displeasure over the anti-smoking nature of Dow- Merrell's Nicorette program. We had been assured that Nicorette would have a low-key introduction and would be aimed only at those smokers who had to stop for medical reasons. Dow continually insisted that they were not taking an anti-cigarette industry position, and backed that assertion two years ago by withdrawing the Smoking Cessation Newsletter. (This document was circulated to physicians and contained much anti-smoking propaganda. Only one issue was printed.) Dow was informed that the recent spate of activity can only be interpreted as a conscious corporate decision that Nicorette is more important than the Philip Morris (and other tobacco) business. That is, they cannot realisti- cally expect a customer to spend millions of dollars for materials, when the profits from those sales, directly or indirectly, are used to attack that customer's product and perhaps reduce the customer's sales. 2023'799799
Page 2: vqy74e00
Mr. A. J. Kay, Jr. - 2 - May 7, 1984 The Dow representatives (who organizationally have no relationship to Dow-Merrell) repeated their previously made claim that Dow was not trying to assault the cigarette industry. However, they could not refute the evidence and were told that we could not deal with intent, but could only assess the documentation in hand which strongly indicates that Dow Chemical is engaged in a program to motivate Philip Morris customers to stop smoking. We indicated that the suspension of business was regrettable since Dow had been a top-notch supplier over the past ten years. Dow responded by saying Philip Morris would remain a priority customer should we desire to purchase materials in the future. Bujold and Ihrig are planning to visit Dow's headquarters in Midland, Michigan to review the situation with corporate management. RDL/lwk cc: G. C. Adkins W. B. Harris L. W. Morgan

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: